The Targeted Oncolytic Poxvirus JX-594 Demonstrates Antitumoral, Antivascular, and Anti-HBV Activities in Patients With Hepatocellular Carcinoma
- Molecular Therapy, Volume 16, Issue 9, September 2008, Pages 1637-1642 | https://doi.org/10.1038/mt.2008.143